Hypoglycaemia caused by secretion of insulin-like growth factor 2 in a primary renal cell carcinoma.
Non-islet cell tumour hypoplycaemia (NICTH) due to the production of an aberrant form of insulin-like growth factor 2 (IGF 2) is a well-recognised phenomenon. This is the first formally reported case occurring in an adult with a primary renal cell carcinoma. This case report describes in detail the various treatment modalities that were used in an attempt to palliate this patient's severe hypoglycaemia.
Berman
J
J
The Meyerstein Institute of Oncology, The Middlesex Hospital, London, UK.
Harland
S
S
D002292:Carcinoma, Renal Cell / Q000097:blood / Q000150:complications / Q000378:metabolism*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000209:etiology*; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000378:metabolism*; D007335:Insulin-Like Growth Factor II / Q000032:analysis / Q000378:metabolism*; D007680:Kidney Neoplasms / Q000097:blood / Q000150:complications / Q000378:metabolism*; D008875:Middle Aged
D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II